These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18675332)

  • 1. Proteomic analysis of human breast cell lines using SELDI-TOF MS shows that mixtures of estrogenic compounds exhibit simple similar action (concentration additivity).
    Zhu Z; Edwards RJ; Boobis AR
    Toxicol Lett; 2008 Sep; 181(2):93-103. PubMed ID: 18675332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteomic (SELDI-TOF-MS) approach to estrogen agonist screening.
    Walker CC; Salinas KA; Harris PS; Wilkinson SS; Watts JD; Hemmer MJ
    Toxicol Sci; 2007 Jan; 95(1):74-81. PubMed ID: 16917070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment.
    Le Moguen K; Lincet H; Marcelo P; Lemoisson E; Heutte N; Duval M; Poulain L; Vinh J; Gauduchon P; Baudin B
    Proteomics; 2007 Nov; 7(22):4090-101. PubMed ID: 17994630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of MCF-7 breast cancer cell line exposed to mitogenic concentration of 17beta-estradiol.
    Malorni L; Cacace G; Cuccurullo M; Pocsfalvi G; Chambery A; Farina A; Di Maro A; Parente A; Malorni A
    Proteomics; 2006 Nov; 6(22):5973-82. PubMed ID: 17051647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.
    Dowling P; Maurya P; Meleady P; Glynn SA; Dowd AJ; Henry M; Clynes M
    Anticancer Res; 2007; 27(3A):1309-17. PubMed ID: 17593624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the endocrine disruptors atrazine and PCB 153 on the protein expression of MCF-7 human cells.
    Lasserre JP; Fack F; Revets D; Planchon S; Renaut J; Hoffmann L; Gutleb AC; Muller CP; Bohn T
    J Proteome Res; 2009 Dec; 8(12):5485-96. PubMed ID: 19778091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.
    Cadron I; Van Gorp T; Amant F; Vergote I; Moerman P; Waelkens E; Daemen A; Van De Plas R; De Moor B; Zeillinger R
    Anticancer Res; 2009 Apr; 29(4):1039-45. PubMed ID: 19414343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of histone proteins during estrogen-mediated cell proliferation.
    Zhu Z; Edwards RJ; Boobis AR
    Environ Health Perspect; 2009 Jun; 117(6):928-34. PubMed ID: 19590685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of estrogen-responsive proteins in MCF-7 human breast cancer cells using label-free quantitative proteomics.
    Zhu Z; Boobis AR; Edwards RJ
    Proteomics; 2008 May; 8(10):1987-2005. PubMed ID: 18491314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SELDI-TOF serum proteomics and breast cancer: which perspective?
    Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
    Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive estrogenic effects of mixtures of frequently used UV filters on pS2-gene transcription in MCF-7 cells.
    Heneweer M; Muusse M; van den Berg M; Sanderson JT
    Toxicol Appl Pharmacol; 2005 Oct; 208(2):170-7. PubMed ID: 16183391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis.
    Zhang H; Feng J; Chang XH; Li ZX; Wu XY; Cui H
    Chin Med J (Engl); 2009 Feb; 122(4):373-6. PubMed ID: 19302738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of SELDI-TOF mass spectrometry to mammalian cell culture.
    Woolley JF; Al-Rubeai M
    Biotechnol Adv; 2009; 27(2):177-84. PubMed ID: 19049820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biomarkers indicating cellular changes after treatment of neuronal cells with the C3 exoenzyme from Clostridium botulinum using the iTRAQ protocol and LC-MS/MS analysis.
    Muetzelburg MV; Hofmann F; Just I; Pich A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1344-51. PubMed ID: 19109081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections.
    Djidja MC; Francese S; Loadman PM; Sutton CW; Scriven P; Claude E; Snel MF; Franck J; Salzet M; Clench MR
    Proteomics; 2009 May; 9(10):2750-63. PubMed ID: 19405023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging mass spectrometry: principles and potentials.
    Chaurand P; Schwartz SA; Reyzer ML; Caprioli RM
    Toxicol Pathol; 2005; 33(1):92-101. PubMed ID: 15805060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics blood testing to distinguish chronic rhinosinusitis subtypes.
    Das S; Maeso PA; Becker AM; Prosser JD; Adam BL; Kountakis SE
    Laryngoscope; 2008 Dec; 118(12):2231-4. PubMed ID: 18978510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.